Product Information
DOXAZOSIN MESYLATE 4 MG TAB is a generic product labeled by Accord Healthcare Inc., priced at $0.0963 per EA under NDC 16729021301. Its NADAC has been published 568 times since Jul 8, 2015.
FDA first approved this application on Jun 11, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Doxazosin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729021301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
DOXAZOSIN MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA202824FDA Approved
6/11/2014
TE Code
AB
On Market Since
4/22/2015
Pharmacological Classes
Price Statistics
The NADAC for DOXAZOSIN MESYLATE 4 MG TAB has been published 568 times since Jul 8, 2015, and over the history we have for it it has declined 80.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0963 per EA |
|---|---|
| All-time high | $0.5203 (Jan 13, 2016) |
| All-time low | $0.0813 (Jul 20, 2022) |
| 52-week high | $0.0975 |
| 52-week low | $0.0912 |
| Median price | $0.1243 |
| Average price | $0.1966 |
| Largest weekly change | -28.7% (Sep 23, 2020) |
| Weeks tracked | 568 |
| Tracking since | Jul 8, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
+0.8%
1Y
+2.3%
3Y
-15.9%
5Y
-14.9%
All
-80.8%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXAZOSIN MESYLATE 4 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DOXAZOSIN MESYLATE 4 MG TAB, manufactured by Accord Healthcare Inc., is $0.0963 per EA (NDC 16729021301), effective May 20, 2026.
How has the price of DOXAZOSIN MESYLATE 4 MG TAB changed over time?
Over the history we have for it, the NADAC for DOXAZOSIN MESYLATE 4 MG TAB has declined 80.8%. It has been tracked across 568 weekly CMS publications since Jul 8, 2015.
What are the highest and lowest recorded NADAC prices for DOXAZOSIN MESYLATE 4 MG TAB?
Since Jul 8, 2015, the NADAC for DOXAZOSIN MESYLATE 4 MG TAB has ranged from a low of $0.0813 (Jul 20, 2022) to a high of $0.5203 (Jan 13, 2016), with a median of $0.1243 per EA.
Are there cheaper alternatives to DOXAZOSIN MESYLATE 4 MG TAB?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXAZOSIN MESYLATE 4 MG TAB, is $0.0857 per EA — about 11% below DOXAZOSIN MESYLATE 4 MG TAB.
Who manufactures DOXAZOSIN MESYLATE 4 MG TAB?
DOXAZOSIN MESYLATE 4 MG TAB (NDC 16729021301) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.